Zimmer Biomet Holdings, Inc. ZBH
NYSE · Healthcare · Medical - Devices
$101.10
Close on Fri, 20 Nov 2026 · market value $19.1B
What the price is betting on
Below its recordAt $101, the price assumes revenue shrinks about 8.4% a year for five years, from $8.6B to about $5.9B by FY2030. That is less than what analysts expect for the next two years and less than the company's own last three years.
Revenue growth a year. The price figure comes from a reverse DCF at a 7.2% discount rate.
Track it and Parra checks each report against the path, and tells you when revenue falls behind it.
Own more than ZBH? Check up to 5 of your stocks at once, free, no account.
Both sides
Three stories, three values
Bear
$183
Base
$206
Bull
$232
Today $101
- Bear $183. Cash flow grows 2% a year for the next 5 years, slower than expected, then slows to long-run growth.
- Base $206. Cash flow grows 4% a year for the next 5 years, as analysts expect, then slows to long-run growth.
- Bull $232. Cash flow grows 6% a year for the next 5 years, faster than expected, then slows to long-run growth.
Stories set by rules from the company’s record.
Checkpoints
The revenue the price needs
- YearNeedsAnalysts expect
- FY2026$8.4B$8.6B, on the path
- FY2027$7.7B$8.9B, on the path
- FY2028$7B$9.2B, on the path
- FY2029$6.5B$9.6B, on the path
- FY2030$5.9B$10B, on the path
Each year's revenue at −8.4% growth from $8.6B in the 12 months to September 2026.
At a glance
Healthcare · Medical - Devices · listed on NYSE
- Revenue, FY2025
- $8.2B
- Growth, 3 years a year
- 5.5%
- Cash margin
- 18%
- Net debt
- $6.9B
- Shares, 3-year change
- −5.5%
- Dividend yield
- 1%
What other healthcare prices are betting on
Figures from company filings and end-of-day market data, as of the close on Fri, 20 Nov 2026; updated every trading day. This page shows what today's price assumes, not whether to buy or sell. Not investment advice.